Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
42.68 USD | +0.12% | +1.45% | +0.66% |
04-18 | Sector Update: Health Care Stocks Mixed Pre-Bell Thursday | MT |
04-18 | Cerevel Therapeutics' Potential Parkinson's Treatment Meets Primary Endpoint in Phase 3 Study | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.66% | 7.74B | |
-0.78% | 104B | |
+5.80% | 97.47B | |
+5.71% | 22.25B | |
-13.05% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-9.97% | 16.36B | |
+8.32% | 14.39B | |
+39.48% | 12.37B |
- Stock Market
- Equities
- CERE Stock
- News Cerevel Therapeutics Holdings, Inc.
- HC Wainwright Trims Price Target on Cerevel Therapeutics Holdings to $48 From $50, Maintains Buy Rating